0113 2727560

Contact Us

Contact CPWY

Twitter Latest Tweets

Latest PSNC News

April 2018 Price Concessions/NCSO – 2nd update

Department of Health and Social Care (DHSC) has today granted the following list of price concessions: Drug Pack size Price Concession Aripiprazole 10mg tablets 28 £3.05 Bicalutamide 150mg tablets 28 £16.94 Co-codamol 30mg/500mg capsules 100 £4.50 Glimepiride 1mg tablets 30 £2.22 Irbesartan 150mg tablets 28 £5.12 Irbesartan 75mg tablets 28 £2.40 Mirtazapine 15mg orodispersible tablets...

2 hours ago

Health & Care Review

Keeping up with all the latest developments in health and care policy could almost be a full time job and PSNC regularly receives questions from LPCs and pharmacy contractors about what is going on in the wider health and care landscape beyond community pharmacy. To help answer some of these questions and to help contractors and...

2 hours ago

Valproate licence change: important information for pharmacy teams

The Medicines and Healthcare products Regulatory Agency (MHRA) has changed the licence for valproate medicines (Epilim, Depakote and generic brands) so it must no longer be prescribed to women or girls of childbearing potential unless they are on the Pregnancy Prevention Programme (PPP). This is because valproate is associated with a significant risk of birth...

8 hours ago

EPS Nominations

It is important if contractors are starting to collect nominations that they are aware of:

  • No inducements can be offered for patients to nominate your pharmacy for EPS R2. This means that money, gifts, points and discounts (along with anything else that may be classed as an inducement) must not be offered or given. The LPC is aware that some contractors do currently offer inducements for signing up to Prescription Collection Services. This must not happen for EPS R2 nominations.
  • Pharmacies must have ‘local accountable auditable processes' for obtaining explicit consent. Consent cannot be assumed to have been given just because a patient is signed up to your PCS service (even if your PCS leaflets make reference to EPS). As part of this consent process there is a range of information that must be given to the patient. Connecting for Health has produced a leaflet called "Explaining the Electronic Prescription Service - Information for patients and carers in England which can be downloaded here. These leaflets can be ordered from the Department of Health's Publication Orderline by clicking here or contacting 0300 123 1002.
  • Community Pharmacy West Yorkshire has produced an EPS Nomination Form to enable you to capture consent for nomination.
  • You may find it useful to have an SOP to cover your nomination processes. Both the NPA and Numark have developed template SOPs.
  • You will not currently be notified if a patient changes their nomination. It is the most recent nomination that counts.
  • Nominations can only be made on an EPS Release 2 system and by an individual with an EPS R2 smartcard. NHS England will be able to track all nominations and will use this data to investigate any issues. You must not share your smartcard with anybody else.
  • You must be aware of the NHS England 'Nomination: what you need to know' document which can be downloaded by clicking here.